temazepam

Product NDC: 71610-262
11-digit product format: 716100262
Labeler code: 71610
Product ID: 71610-262_fd379748-a9f4-4151-8531-8029b2aa6885
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: temazepam
Dosage form: CAPSULE
Route: ORAL
Labeler: Aphena Pharma Solutions - Tennessee, LLC
Application: ANDA071457
Marketing category: ANDA
Marketing start: 1987-04-21
Marketing end: 0000-00-00
Substance: TEMAZEPAM
Active strength: 30 mg/1
Pharmacologic classes: Benzodiazepine [EPC],Benzodiazepines [CS]
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	71610-262		I	Inactivated by FDA	2026-10-05
excluded package	package	71610-262	71610-262-28	I	Inactivated by FDA	2026-10-05
excluded package	package	71610-262	71610-262-60	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	71610-262-28	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	71610-262-60	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	71610-262-28	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	71610-262-60	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71610-262-28	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71610-262-60	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71610-262-28	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71610-262-60	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71610-262-28	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71610-262-60	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71610-262-28	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71610-262-60	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71610-262-28	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71610-262-60	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71610-262-28	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71610-262-60	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71610-262-28	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71610-262-60	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	71610-262-28	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	71610-262-60	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	71610-262-28	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	71610-262-60	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	71610-262-28	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	71610-262-60	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	71610-262-28	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	71610-262-60	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	71610-262-28	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	71610-262-60	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	71610-262-28	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	71610-262-60	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	71610-262-28	E	Excluded after deficient or non-compliant submission was not corrected	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	71610-262-60	E	Excluded after deficient or non-compliant submission was not corrected	`fb8cb913e6d1…`	`eb8c232b6be0…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A071457-001	TEMAZEPAM	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21
A071457-002	TEMAZEPAM	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22
A071457-003	TEMAZEPAM	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A071457-001	AB
A071457-002	AB
A071457-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A071457-002	TEMAZEPAM	7.5MG	CAPSULE / ORAL	AB	2012-06-22	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A071457-003	TEMAZEPAM	22.5MG	CAPSULE / ORAL	AB	2012-06-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A071457-001	TEMAZEPAM	30MG	CAPSULE / ORAL	AB	1987-04-21	`301d65b070ca…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A071457-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A071457-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A071457-003	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A071457-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A071457-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A071457-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A071457-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A071457-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A071457-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A071457-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A071457-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A071457-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A071457-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A071457-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A071457-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A071457-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A071457-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A071457-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A071457-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A071457-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A071457-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A071457-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A071457-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A071457-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A071457-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A071457-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A071457-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A071457-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A071457-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A071457-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A071457-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A071457-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A071457-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A071457-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A071457-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A071457-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A071457-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A071457-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A071457-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A071457-001	AB	1	`301d65b070ca…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a3aa44f1-a660-94b4-7185-b48df8b066ff	Product name	5	20250522

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
71610-262-28	2023-01-30	C162847	48780-1	f386c64a-2d70-0266-e053-dadaa90a7c1a	d8b31e15-c12f-4830-863c-64316337d8fa
71610-262-60	2023-01-30	C162847	48780-1	f386c64a-2d70-0266-e053-dadaa90a7c1a	d8b31e15-c12f-4830-863c-64316337d8fa

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
71610-262-28	temazepam	28 in 1 BOTTLE	CAPSULE	28		1
71610-262-60	temazepam	90 in 1 BOTTLE	CAPSULE	90		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71610-262	TEMAZEPAM CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1	Legacy NDC, 2 package rows	20190504_d8b31e15-c12f-4830-863c-64316337d8fa.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 23 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
temazepam	TEMAZEPAM	Bryant Ranch Prepack	5d83e474-0932-49ae-ad92-ca278cd5f1d5	2026-09-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Bryant Ranch Prepack	1c08d30d-7c27-a09a-5240-7050771d5cc7	2026-09-08	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
Temazepam	TEMAZEPAM	Major Pharmaceuticals	2c4f564d-d349-4f9b-b3f4-f3f0d9706a4d	2026-09-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	PD-Rx Pharmaceuticals, Inc.	62379cd5-a314-43eb-a1ee-33997623bfa3	2026-08-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Ascend Laboratories, LLC	8f54731f-c5b7-492c-acb0-444c5fbb7029	2026-08-05	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Preferred Pharmaceuticals Inc.	7e3fd8fe-fb8a-4577-b540-0e3fefe63627	2026-01-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Bryant Ranch Prepack	4fe8192a-0f65-4958-8b6d-e87b9fae9eb5	2025-11-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Bryant Ranch Prepack	bbb6e233-dc6b-43a7-8203-d91421d89921	2025-11-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	A-S Medication Solutions	19b2711e-587a-47d2-ab62-d564e7b87195	2025-10-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Bryant Ranch Prepack	dadc2f66-7fa5-4be4-a9d0-d96e5836f550	2025-10-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Asclemed USA, Inc.	254a0273-c0f3-4d2d-b18e-4ab51ba4bc50	2025-10-08	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	AvPAK	08183adb-af12-fcb2-e063-6394a90afea4	2025-01-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Bryant Ranch Prepack	ed068e02-a9c6-41ce-beca-83762720663d	2024-11-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Bryant Ranch Prepack	8af67441-167f-4cc8-a498-c4377ba41c6d	2024-08-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	NuCare Pharmaceuticals,Inc.	62fc08cd-8143-1652-e053-2a91aa0ad7ed	2024-08-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Bryant Ranch Prepack	6559dfee-c29b-4707-8b30-8ca14bf23ea0	2024-03-22	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Bryant Ranch Prepack	147a51d7-2f8d-43e8-b0ed-a79a2cdfc0a9	2024-03-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Aphena Pharma Solutions - Tennessee, LLC	b2422ca0-2f06-419f-aa0e-88c556b62399	2024-01-23	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Bryant Ranch Prepack	1e37d59b-b8be-46ef-8706-fffd563a8c15	2024-01-11	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457
temazepam	TEMAZEPAM	Bryant Ranch Prepack	0e752dda-f00f-4123-b59f-aa911b897a5a	2023-12-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071457 application number: ANDA071457

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
CHB1QD2QSS	TEMAZEPAM	846-50-4	TEMAZEPAM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
198242	temazepam 30 MG Oral Capsule	PSN	d8b31e15-c12f-4830-863c-64316337d8fa	1
198242	temazepam 30 MG Oral Capsule	SCD	d8b31e15-c12f-4830-863c-64316337d8fa	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
71610-262-28	71610026228	28 CAPSULE in 1 BOTTLE (71610-262-28)	28 capsule	2019-04-25	0000-00-00	No	No	Current
71610-262-60	71610026260	90 CAPSULE in 1 BOTTLE (71610-262-60)	90 capsule	2019-04-25	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
temazepam - Aphena Pharma Solutions - Tennessee, LLC	Aphena Pharma Solutions - Tennessee, LLC	2019-04-25	Human Prescription Drug Label	1